Eva Cristobal

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Corrigendum to "HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study" [Gynecologic Oncology 194 (2025) 33-40].

Corrigendum to "HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study" [Gynecologic Oncology 194 (2025) 33-40].

Journal: Gynecologic oncology

Published: November 09, 2025

HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study.

HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study.

Journal: Gynecologic oncology

Published: November 06, 2024

The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).

The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).

Journal: International journal of molecular sciences

Published: May 09, 2023

The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors.

The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors.

Journal: The American journal of surgical pathology

Published: July 25, 2022

Progression to lung fibrosis in severe COVID-19 patients: A morphological and transcriptomic study in postmortem samples.

Progression to lung fibrosis in severe COVID-19 patients: A morphological and transcriptomic study in postmortem samples.

Journal: Frontiers in medicine

Published: June 23, 2022

Molecular Heterogeneity of High Grade Colorectal Adenocarcinoma.

Molecular Heterogeneity of High Grade Colorectal Adenocarcinoma.

Journal: Cancers

Published: October 28, 2020

Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification.

Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification.

Journal: The American journal of surgical pathology

Published: May 09, 2020

Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and Consequences.

Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and Consequences.

Journal: The American journal of surgical pathology

Published: April 16, 2020

The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO).

The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO).

Journal: The American journal of surgical pathology

Published: September 10, 2019

Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma.

Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma.

Journal: Cancers

Published: May 24, 2019

High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features.

High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features.

Journal: Cancers

Published: November 16, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026